Reckitt Benckiser Group (LON:RB) had its target price dropped by JPMorgan Chase & Co. from GBX 7,700 ($101.29) to GBX 6,500 ($85.50) in a research report issued on Tuesday, Borsen Zeitung reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 5.30% from the company’s current price.

RB has been the subject of several other reports. Citigroup reissued a “buy” rating on shares of Reckitt Benckiser Group in a report on Wednesday, March 11th. Barclays cut their price target on shares of Reckitt Benckiser Group from GBX 6,700 ($88.13) to GBX 6,400 ($84.19) and set a “buy” rating for the company in a report on Tuesday. Deutsche Bank reissued a “buy” rating and issued a GBX 7,200 ($94.71) price target on shares of Reckitt Benckiser Group in a report on Thursday, February 27th. Royal Bank of Canada reissued an “underperform” rating on shares of Reckitt Benckiser Group in a report on Friday, March 6th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 7,150 ($94.05) price target on shares of Reckitt Benckiser Group in a report on Friday, February 28th. Three analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of GBX 6,355 ($83.60).

RB traded up GBX 223 ($2.93) on Tuesday, hitting GBX 6,173 ($81.20). The company’s stock had a trading volume of 4,044,904 shares, compared to its average volume of 1,720,000. The company’s 50 day simple moving average is GBX 6,093.46 and its 200-day simple moving average is GBX 6,103.72. The firm has a market cap of $44.22 billion and a P/E ratio of -11.88. Reckitt Benckiser Group has a 12 month low of GBX 5,510 ($72.48) and a 12 month high of GBX 8,191.30 ($107.75). The company has a quick ratio of 0.41, a current ratio of 0.56 and a debt-to-equity ratio of 130.80.

In related news, insider Laxman Narasimhan acquired 17,241 shares of the stock in a transaction dated Tuesday, March 3rd. The shares were purchased at an average price of GBX 5,800 ($76.30) per share, for a total transaction of £999,978 ($1,315,414.36).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: Overbought

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.